Tech in 2024: AI and Dividends
Motley Fool Money
00:00
Navigating the Pharmaceutical Landscape
This chapter explores the current earnings season, especially in REITs, while analyzing the pharmaceutical industry's challenges due to patent expirations. It highlights the differences between traditional drugs and biologics, detailing the complexities of biosimilars and their market implications. The discussion also covers strategies pharmaceutical companies employ to navigate patent laws and enhance drug delivery methods, all within the evolving landscape of drug pricing and competition.
Transcript
Play full episode
